Key result
Abnormal ankle-brachial index linked to ~77% higher risk of incident cardiovascular events.
Why the study?
It is unknown whether the association of low and high ankle-brachial index with incident cardiovascular events is consistent across ethnic groups and independent of newer biomarkers and other subclinical CVD measures.
Does a low or high ankle-brachial index predict incident cardiovascular events in a multi-ethnic cohort free of clinical CVD at baseline?
Cohort (n=6,647)
Yes
Does a low or high ankle-brachial index predict incident cardiovascular events in a multi-ethnic cohort free of clinical CVD at baseline?
Hazard Ratio: 1.77
p-value: p=<0.001
Ankle-brachial index values both below 1.00 and 1.40 or greater independently predict incident cardiovascular events beyond traditional and newer subclinical biomarkers.
ABI may refine CVD risk stratification beyond traditional markers in multi-ethnic adults; extends prior associations but leaves practice change open.
Objectives The purpose of this study was to examine the association of both a low and a high ankle-brachial index (ABI) with incident cardiovascular events in a multi-ethnic cohort. Background Abnormal ankle-brachial indices (ABIs), both low and high, are associated with elevated cardiovascular disease (CVD) risk. However, it is unknown whether this association is consistent across different ethnic groups, and whether it is independent of both newer biomarkers and other measures of subclinical atherosclerotic CVD. Methods 6647 non-Hispanic white, African-American, Hispanic, and Chinese men and women aged 45–84 years from free-living populations in six United States field centers and free of clinical CVD at baseline had extensive measures of traditional and newer biomarker risk factors, and measures of subclinical CVD, including the ABI. Incident CVD, defined as coronary disease, stroke, or other atherosclerotic CVD death, was determined over a mean follow-up of 5.3 years. Results Both a low (<1.00) and a high (≥ 1.40) ABI were associated with incident CVD events. Gender- specific and ethnic-specific analyses showed consistent results. Hazard ratios were 1.77 (p<.001) for a low and 1.85 (p=.050) for a high ABI after adjustment for both traditional and newer biomarker CVD risk factors, and the ABI significantly improved risk discrimination. Further adjustment for coronary artery calcium score, common and internal carotid intimal medial thickness, and major ECG abnormalities only modestly attenuated these hazard ratios. Conclusions In this study both a low and a high ABI were associated with elevated CVD risk in persons free of known CVD, independent of standard and novel risk factors, and independent of other measures of subclinical CVD. Further research should address the cost-effectiveness of measuring the ABI in targeted population groups.
No takes yet. Share an insight, caveat, or question.
Criqui et al. (2010) conducted a cohort in Free of clinical cardiovascular disease (n=6,647). Low (<1.00) or high (≥1.40) ankle-brachial index vs. Normal ankle-brachial index (1.00-1.39) was evaluated on Incident cardiovascular events (coronary disease, stroke, or other atherosclerotic CVD death) (HR 1.77, p=<0.001). Low (<1.00) and high (≥ 1.40) ankle-brachial indices were associated with an increased risk of incident cardiovascular events (HR 1.77 and HR 1.85, respectively) independent of other risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: